Lv1
16 积分 2022-02-28 加入
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion
4个月前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
4个月前
已完结
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
6个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
6个月前
已完结
DEVELOPMENT OF THE PIN-POINTTM PLATFORM: A VERSATILE BASE EDITING TECHNOLOGY WITH BROAD CAS ENZYME AND DEAMINASE COMPATIBILITY FOR CELL AND GENE THERAPY
8个月前
已关闭
DEVELOPMENT OF THE PIN-POINTTM PLATFORM: A VERSATILE BASE EDITING TECHNOLOGY WITH BROAD CAS ENZYME AND DEAMINASE COMPATIBILITY FOR CELL AND GENE THERAPY
8个月前
已完结
皖公网安备34019202002308
